ABBVIE INC revenue for the last year amounted to 45.73 B CHF, the most of which — 22.00 B CHF — came from its highest performing source at the moment, Immunology, the year earlier bringing 26.75 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought ABBVIE INC 35.26 B CHF, and the year before that — 42.27 B CHF.